An investigational cell therapy being evaluated at Health has been granted fast-track designation by the U.S. Food and Drug Administration to help patients with oropharyngeal dysphagia ...

The FDA granted regenerative medicine advanced therapy designation to iltamciocel for patients with oropharyngeal dysphagia following head and neck cancer treatment.

Therapy Program, developed by Parkinson Voice Project, is a research evidence-based program helping individuals diagnosed with Parkinson’s and related neurological disorders regain and retain their ...

There is a notable gap in public awareness and knowledge of dysphagia compared with other conditions, according to a study published online.

This treatment helps individuals with Parkinson’s disease to regain and retain their speech and communication skills while minimizing swallowing issues. SPEAK OUT!® combines education for the patient ...

Adults can present with dysphagia, heartburn ... Although PPIs are not considered first-line therapy, they may be prescribed for symptomatic treatment. These medications can help reduce acid ...

Treatment with gene therapy candidate BB-301 led to improvements in swallowing ability for the first three OPMD patients in a clinical trial.